Why the study?
The study was conducted to evaluate the incidence, predictors, and clinical outcome of device-related thrombus after left atrial appendage occlusion in patients with atrial fibrillation.
What are the incidence and predictors of device-related thrombus after left atrial appendage occlusion in patients with non-valvular atrial fibrillation?
What are the incidence and predictors of device-related thrombus after left atrial appendage occlusion in patients with non-valvular atrial fibrillation?
Device-related thrombus after LAAO occurs in nearly 10% of patients and is strongly predicted by patient comorbidities (MI, HF) and procedural factors (residual leak >5 mm), highlighting the need for careful follow-up in high-risk patients.
Prior MI and residual leak >5 mm flag elevated DRT risk after LAAO; supports targeted surveillance while leaving management open in observational data.
Aim . To study the incidence, predictors, and clinical outcome of device-related thrombus (DRT) after left atrial appendage occlusion (LAAO) in patients with atrial fibrillation (AF). Methods. A prospective observational study included 120 patients with non-valvular AF who underwent LAAO with Watchman (n=92) and Amplatzer Amulet (n=28). The presence of device-related thrombus (DRT) was assessed at visits 45 days, 6 months, 1 year, 2 years, 3 years after implantation by transesophageal echocardiography. Results . A total of 11 (9.2%) patients had DRT during the follow-up period. The greatest number of thrombosis was observed after 45 days (n=4) and after 6 months (n=4). There was no significant difference in the incidence of DRT between device types. Independent predictors of thrombosis were: history of myocardial infarction (hazard ratio (HR) 12.88 [95% confidence interval (CI) 3.21-51.62]; p<0.001), chronic heart failure (HR 8.83 [95% CI 1.91-40.77]; p=0.005), residual leak size >5 mm in the early postoperative period (HR 6.13 [95% CI 2.53-14.86]; p<0.001) and the degree of spontaneous echo contrast during the initial examination (HR 9.09 [95% CI 1.36-60.58], p=0.023). There were no cases of thromboembolic complications associated with DRT. One patient developed a non-fatal stroke at 35 weeks of follow-up, while DRT was detected at the visit at the end of the 3rd year of follow-up. Conclusion. DRT after LAAO was observed in the early and long-term follow-up periods. This event was associated with the baseline patients’ characteristics and post-procedural aspects with no dependence on type of antithrombotic therapy.
No takes yet. Share an insight, caveat, or question.
Певзнер et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: